{
  "id": 2308,
  "text": "& Helmerhorst, T.J.Prognostic factors in adenocarcinoma of the uterine cervix.Gynecol Oncol 92, 262-267 (2004).16.Alfsen, G.C., Kristensen, G.B., Skovlund, E., Pettersen, E.O.& Abeler, V.M.Histologic subtype has minor importance for overall survival in patients with adenocarcinoma of the uterine cervix: a population-based study of prognostic factors in 505 patients with nonsquamous cell carcinomas of the cervix.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: & Helmerhorst, T.J.Prognostic factors in adenocarcinoma of the uterine cervix.Gynecol Oncol 92, 262-267 (2004).16.Alfsen, G.C., Kristensen, G.B., Skovlund, E., Pettersen, E.O.& Abeler, V.M.Histologic subtype has minor importance for overall survival in patients with adenocarcinoma of the uterine cervix: a population-based study of prognostic factors in 505 patients with nonsquamous cell carcinomas\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "宫颈腺癌患者的预后因素包括以下几个重要方面：\n\n1. **肿瘤分期**：肿瘤的分期是影响宫颈腺癌患者预后的关键因素。疾病越晚期，预后通常越差。\n\n2. **淋巴结转移**：是否存在淋巴结转移是重要的预后指标。淋巴结阳性患者的生存率低于淋巴结阴性患者。\n\n3. **肿瘤大小**：较大的肿瘤通常与更差的预后相关。\n\n4. **血管和淋巴管浸润（LVSI）**：肿瘤浸润到血管或淋巴管中表明疾病可能更具侵袭性。\n\n5. **组织学亚型**：根据研究，虽然组织学亚型对总体生存率的影响较小，但不同的亚型可能与疾病的生物学行为相关。\n\n6. **治疗方式**：接受手术、放疗或化疗的患者预后可能不同，治疗的及时性和个体化方案尤为重要。\n\n结合患者的具体临床病史和上述因素，医生会进一步评估疾病的发展并制定合适的治疗方案。",
  "query": "宫颈腺癌患者的预后因素有哪些？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 宫颈腺癌患者的预后因素有哪些？\n\n<reference text>: & Helmerhorst, T.J.Prognostic factors in adenocarcinoma of the uterine cervix.Gynecol Oncol 92, 262-267 (2004).16.Alfsen, G.C., Kristensen, G.B., Skovlund, E., Pettersen, E.O.& Abeler, V.M.Histologic subtype has minor importance for overall survival in patients with adenocarcinoma of the uterine cervix: a population-based study of prognostic factors in 505 patients with nonsquamous cell carcinomas of the cervix.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "宫颈腺癌患者的预后因素包括以下几个重要方面：\n\n1. **肿瘤分期**：肿瘤的分期是影响宫颈腺癌患者预后的关键因素。疾病越晚期，预后通常越差。\n\n2. **淋巴结转移**：是否存在淋巴结转移是重要的预后指标。淋巴结阳性患者的生存率低于淋巴结阴性患者。\n\n3. **肿瘤大小**：较大的肿瘤通常与更差的预后相关。\n\n4. **血管和淋巴管浸润（LVSI）**：肿瘤浸润到血管或淋巴管中表明疾病可能更具侵袭性。\n\n5. **组织学亚型**：根据研究，虽然组织学亚型对总体生存率的影响较小，但不同的亚型可能与疾病的生物学行为相关。\n\n6. **治疗方式**：接受手术、放疗或化疗的患者预后可能不同，治疗的及时性和个体化方案尤为重要。\n\n结合患者的具体临床病史和上述因素，医生会进一步评估疾病的发展并制定合适的治疗方案。"
}